My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 209

    1.

    Did prescription bias affect outcomes in a study of the relative effectiveness of osteoporosis drugs?

    Beri A, Khattri S.

    Ann Intern Med. 2008 Oct 7;149(7):514; author reply 514. No abstract available. PMID: 18838735 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Assessing the relative efficacy of different agents based on the outcomes from meta-analyses.

    Boonen S, Vanderschueren D, Haentjens P.

    Int J Clin Pract. 2008 Jan;62(1):164-5; author reply 165-6. No abstract available. PMID: 18173819 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    [Effectiveness of anti-resorption therapies of postmenopausal osteoporosis]

    Stĕpán J.

    Vnitr Lek. 2007 Mar;53(3):293-9. Review. Czech. PMID: 17503641 [PubMed - indexed for MEDLINE]Related articles

    4.

    Ten vs five years of bisphosphonate treatment for postmenopausal osteoporosis: enough of a good thing.

    Colón-Emeric CS.

    JAMA. 2006 Dec 27;296(24):2968-9. No abstract available. PMID: 17190899 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Strontium ranelate and non-vertebral fracture in postmenopausal osteoporosis]

    Callejas Rubio JL, López Pérez L, Sánchez Cano D, Ortego Centeno N.

    Med Clin (Barc). 2006 Jul 15;127(7):279. Spanish. No abstract available. PMID: 16942738 [PubMed - indexed for MEDLINE]Related articles

    6.

    Summaries for patients. Drug therapy for osteoporosis.

    [No authors listed]

    Ann Intern Med. 2008 May 6;148(9):I28. No abstract available. PMID: 18458273 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Denosumab, osteoporosis, and prevention of fractures.

    Blackwood J.

    N Engl J Med. 2009 Nov 26;361(22):2189; author reply 2190-1. No abstract available. PMID: 19950411 [PubMed - indexed for MEDLINE]Related articles

    8.

    Denosumab, osteoporosis, and prevention of fractures.

    Blythe SL.

    N Engl J Med. 2009 Nov 26;361(22):2189-90; author reply 2190-1. No abstract available. PMID: 19950410 [PubMed - indexed for MEDLINE]Related articles

    9.

    [New bone density conservation agents for osteoporosis under research and development: Minodronic acid]

    Takata S.

    Nippon Rinsho. 2007 Nov 28;65 Suppl 9:417-20. Review. Japanese. No abstract available. PMID: 18161142 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Does ibandronate (Bonviva) have an impact on non-vertebral fractures?]

    Kastelan D, Vlak T.

    Reumatizam. 2007;54(2):87-8. Review. Croatian. No abstract available. PMID: 18351153 [PubMed - indexed for MEDLINE]Related articles

    11.

    Use of alendronate after 5 years of treatment.

    Delmas PD.

    JAMA. 2007 May 9;297(18):1979-80; author reply 1980-1. No abstract available. PMID: 17488957 [PubMed - indexed for MEDLINE]Related articles

    12.

    Update on postmenopausal osteoporosis management.

    Clunie G.

    Clin Med. 2007 Jan-Feb;7(1):48-52. Review. No abstract available. PMID: 17348575 [PubMed - indexed for MEDLINE]Related articles

    13.

    Persistence with bisphosphonate therapy in older people.

    Melo M, Qiu F, Sykora K, Juurlink D, Laupacis A, Mamdani M.

    J Am Geriatr Soc. 2006 Jun;54(6):1015-6. No abstract available. PMID: 16776810 [PubMed - indexed for MEDLINE]Related articles

    14.

    Use of alendronate after 5 years of treatment.

    Erviti J, Gorricho J.

    JAMA. 2007 May 9;297(18):1979; author reply 1980-1. No abstract available. PMID: 17488959 [PubMed - indexed for MEDLINE]Related articles

    15.

    Use of alendronate after 5 years of treatment.

    Ott SM.

    JAMA. 2007 May 9;297(18):1979; author reply 1980-1. No abstract available. PMID: 17488958 [PubMed - indexed for MEDLINE]Related articles

    16.

    Renal function and bisphosphonate safety.

    Ott SM, Drueke T, Elder G, Fukagawa M, Jorgetti V, Langman CB, Moe S, McCann L, Wang AY, Weisinger J, Wheeler D.

    J Bone Miner Res. 2008 Mar;23(3):453-4; author reply 455. No abstract available. PMID: 17967135 [PubMed - indexed for MEDLINE]Related articles

    17.

    Under-use of bisphosphonates in rural elderly women who have sustained fractures.

    Naunton M, Peterson G, Jones G.

    Aust J Rural Health. 2006 Dec;14(6):286. No abstract available. PMID: 17121511 [PubMed - indexed for MEDLINE]Related articles

    18.

    Fracture risk in postmenopausal women.

    Landis DM.

    Nurse Pract. 2005 Nov;30(11):48, 53-8. Review. No abstract available. PMID: 16276300 [PubMed - indexed for MEDLINE]Related articles

    19.

    Yearly zoledronic acid in postmenopausal osteoporosis.

    Najib MA, Aziz I.

    N Engl J Med. 2007 Aug 16;357(7):713; author reply 714-5. No abstract available. PMID: 17703527 [PubMed - indexed for MEDLINE]Related articles

    20.

    Evidence-based prescribing of antiresorptive therapy for female nursing home residents with osteoporosis: how good is the evidence?

    Cheng HY.

    J Am Geriatr Soc. 2006 Feb;54(2):375-6. No abstract available. PMID: 16460401 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity